14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $137.78 $156.84 Wednesday, 24th Apr 2024 ASND stock ended at $143.18. This is 1.14% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.56% from a day low at $141.06 to a day high of $144.68.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Feb 11, 2022 $124.99 $128.97 $121.93 $122.84 99 600
Feb 10, 2022 $123.04 $128.55 $122.65 $123.51 227 900
Feb 09, 2022 $124.10 $128.41 $124.10 $125.00 147 400
Feb 08, 2022 $120.01 $124.02 $118.13 $123.44 159 800
Feb 07, 2022 $122.39 $126.08 $119.82 $120.99 133 700
Feb 04, 2022 $115.92 $122.74 $113.85 $121.81 238 000
Feb 03, 2022 $118.75 $119.52 $115.40 $115.84 125 500
Feb 02, 2022 $120.98 $121.25 $118.40 $120.47 170 600
Feb 01, 2022 $122.11 $125.42 $119.36 $121.27 260 600
Jan 31, 2022 $119.17 $123.86 $119.17 $121.64 308 400
Jan 28, 2022 $115.75 $120.30 $111.20 $119.76 278 200
Jan 27, 2022 $118.00 $120.10 $112.60 $115.01 412 400
Jan 26, 2022 $114.77 $120.62 $112.80 $116.16 445 900
Jan 25, 2022 $113.82 $115.87 $109.34 $113.58 390 200
Jan 24, 2022 $107.34 $116.46 $104.59 $115.02 893 000
Jan 21, 2022 $110.02 $113.28 $105.72 $107.97 434 100
Jan 20, 2022 $119.81 $126.75 $110.57 $111.14 297 600
Jan 19, 2022 $117.86 $122.42 $116.59 $118.29 145 300
Jan 18, 2022 $121.64 $121.64 $116.48 $117.51 369 900
Jan 14, 2022 $119.05 $128.49 $116.79 $122.96 246 300
Jan 13, 2022 $123.00 $128.04 $118.34 $119.05 488 200
Jan 12, 2022 $118.90 $122.63 $117.19 $121.85 245 100
Jan 11, 2022 $116.07 $122.77 $116.07 $118.88 205 100
Jan 10, 2022 $114.86 $116.78 $111.96 $116.18 281 600
Jan 07, 2022 $121.18 $122.17 $116.33 $116.86 123 900
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT